U.S. Cuts HIV Aid to South Africa, Leaving Millions at Risk by 2025
U.S. Cuts HIV Aid to South Africa, Leaving Millions at Risk by 2025
U.S. Cuts HIV Aid to South Africa, Leaving Millions at Risk by 2025
The U.S. has begun withdrawing financial support from South Africa, affecting key health programmes. In January 2025, President Donald Trump halted aid, citing concerns over Black Economic Empowerment policies and land expropriation laws. The move has triggered significant disruptions in the country’s HIV response efforts. The U.S. State Department is now phasing out the President’s Emergency Plan for AIDS Relief (PEPFAR) in South Africa. Most of its programmes are set to close by September 2025. PEPFAR previously covered about 17% of the national HIV programme budget, excluding antiretroviral drugs.
The withdrawal has already led to the closure of support facilities in 27 districts. Frontline workers and volunteers have lost their jobs, while HIV prevention services have been severely reduced. Civil society groups, including Section27, report that adolescent girls and women are among the hardest hit.
Before the cuts, the U.S. demanded that senior South African officials publicly condemn the song 'Kill the Boer' to prevent the withdrawal. South Africa, which has the world’s largest HIV-positive population at around 8 million people, announced a $45 million emergency fund last year to address the gaps left by PEPFAR. The health department has also been developing a self-reliance plan since January 2025 to lessen the impact. The phase-out of PEPFAR funding is expected to conclude by September 2025. South Africa’s emergency measures aim to fill the financial void left by the U.S. withdrawal. The country now faces the challenge of sustaining its HIV programmes without external support.
U.S. Cuts HIV Aid to South Africa, Leaving Millions at Risk by 2025
A political standoff over land policies triggers a health catastrophe. With PEPFAR gone, South Africa scrambles to save its lifeline HIV services before time runs out.
Human enzymes defy science by producing key metabolites without gut microbes
What if your body—not just bacteria—controls vital chemical processes? A groundbreaking study rewrites the rules of metabolism, with major implications for medicine and drug development.
Joe Manganiello opens up about his seven-year battle with mystery illnesses
From undiagnosed suffering to shamanic rituals, his story is raw and revelatory. Bloodlines exposes the pain—and resilience—behind the Hollywood smile.
H5N1 avian flu takes a deadly turn in dairy cattle with udder infections
A virus known for attacking lungs now devastates udders—changing everything we thought about H5N1. Raw milk may carry hidden dangers for farm workers.